Thermo Fisher Scientific Net Income decreased by 15.9% to $1.65B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.6%, from $1.51B to $1.65B. Over 4 years (FY 2021 to FY 2025), Net Income shows a downward trend with a -3.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
The most common metric for evaluating company performance against industry competitors.
net_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.83B | $1.90B | $1.66B | $2.22B | $1.67B | $1.50B | $1.57B | $1.29B | $1.36B | $1.70B | $1.61B | $1.33B | $1.55B | $1.63B | $1.83B | $1.51B | $1.62B | $1.62B | $1.96B | $1.65B |
| QoQ Change | — | +4.0% | -12.7% | +33.7% | -24.9% | -10.2% | +5.1% | -17.9% | +5.4% | +24.4% | -5.3% | -17.1% | +16.7% | +4.9% | +12.0% | -17.4% | +7.3% | -0.1% | +21.5% | -15.9% |
| YoY Change | — | — | — | — | -8.8% | -21.2% | -5.2% | -41.8% | -18.3% | +13.2% | +2.0% | +3.0% | +14.0% | -3.9% | +13.6% | +13.2% | +4.1% | -0.8% | +7.6% | +9.6% |